ORBIMED ADVISORS LLC 13D and 13G filings for Adicet Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-21 4:31 pm Unchanged |
2024-03-19 | 13D | Adicet Bio, Inc. ACET |
ORBIMED ADVISORS LLC | 9,772,598 11.900% |
0 (Unchanged) |
Filing |
| 2024-01-29 4:55 pm Purchase |
2024-01-25 | 13D | Adicet Bio, Inc. ACET |
ORBIMED ADVISORS LLC | 9,772,598 12.900% |
3,125,000 (+47.01%) |
Filing |
| 2023-06-29 4:30 pm Purchase |
2023-06-27 | 13D | Adicet Bio, Inc. ACET |
ORBIMED ADVISORS LLC | 6,647,598 15.500% |
6,647,598 (New Position) |
Filing |